ARTICLE | Clinical News
Soluble Beta Glucan: Completed Phase III enrollment
September 14, 2009 7:00 AM UTC
Biotec Pharmacon completed enrollment of 130 patients in a double-blind, placebo-controlled, European Phase III trial. SBG has Orphan Drug designation in the EU for the indication. ...